Women's Health Therapeutics Market Size to Grow by USD 30.35 billion, Rising Awareness about Gynecological Diseases to be a Key Trend – Technavio

NEW YORK, Sept. 27, 2022 /PRNewswire/ — One of the key trends in the women’s health therapeutics market will be the rising awareness about gynecological diseases. Various organizations are working toward increasing awareness about gynecological diseases such as maternity disorders, cancer, and infectious diseases. For instance, the Centers for Disease Control and Prevention (CDC) conducts Inside Knowledge: Get the Facts About Gynecologic Cancer campaign, which provides information about gynecological cancers. Similarly, September is observed as Gynecologic Cancer Awareness Month every year by the Foundation for Women Cancer in the US. In addition, some organizations focus on increasing patient awareness about the major sub-types of gynecological disorders. Such awareness campaigns are expected to drive the growth of the global women’s therapeutics market during the forecast period.

The women’s health therapeutics market size is expected to grow by USD 30.35 billion from 2021 to 2026. In addition, the growth momentum of the market will accelerate at a CAGR of 5.74% during the forecast period, according to Technavio. Strategic alliances are driving market growth. However, factors such as the side effects of approved drugs will challenge the market growth.

Get a comprehensive report summary that describes the market size and forecast along
with research methodology. The FREE sample report is available in PDF format

Women’s Health Therapeutics Market: Type Landscape

By type, the market has been segmented into fertility, oncology, menopause, infection, and others. The fertility segment will be the largest contributor to market growth during the forecast period. This growth is attributed to factors such as the increase in the incidence of gynecological cancers in countries such as the US and Canada.

Women’s Health Therapeutics Market: Geographic Landscape

By geography, the market has been segmented into North America, Europe, Asia, and the Rest of the World (ROW). North America is expected to have lucrative growth during the forecast period. About 37% of the market’s overall growth is expected to originate from this region. The US and Canada are the key countries for the women’s health therapeutics market in North America.

Key Companies Covered and their Offerings

Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, Mithra Pharmaceuticals SA, among others, are the main players in the market. The key offerings of some of these vendors are listed below:

  • Abbott Laboratories – The company offers women’s health therapeutics such as Arachitol O, B Crip, and Clome.
  • AbbVie Inc. – The company offers women’s health therapeutics such as Orilissa and Oriahnn.
  • Amgen Inc. – The company offers women’s health therapeutics such as Xgeva and Evenity.
  • Eli Lilly and Co. – The company offers women’s health therapeutics such as Forteo.
  • F. Hoffmann La Roche Ltd. – The company offers women’s health therapeutics such as Elecsys AMH and Elecsys sFlt 1.

This report provides a full list of key vendors, their strategies, and the latest
developments. Request a FREE PDF Sample Now

What our reports offer

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers market data for 2021, 2022, until 2026
  • Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Related Reports

Stem Cell Umbilical Cord Blood (UCB) Market by End-user and Geography – Forecast and Analysis 2022-2026: The stem cell umbilical cord blood (UCB) market share is expected to increase by USD 1.47 bn from 2021 to 2026.

Amniotic Membrane Market by Type and Geography – Forecast and Analysis 2022-2026: The amniotic membrane market share is expected to increase by USD 1.86 billion from 2021 to 2026.

Women’s Health Therapeutics Market Scope

Report Coverage

Details

Page number

120

Base year

2021

Forecast period

2022-2026

Growth momentum & CAGR

Accelerate at a CAGR of 5.74%

Market growth 2022-2026

USD 30.35 billion

Market structure

Fragmented

YoY growth (%)

5.04

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 37%

Key consumer countries

US, Canada, Germany, UK, and China

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Abbott Laboratories, AbbVie Inc., Amgen Inc., Bayer AG, Eli Lilly and Co., F. Hoffmann La Roche Ltd., GLS Pharma Pvt. Ltd., ICON plc, Merck KGaA, Novartis AG, Novo Nordisk AS, ObsEva SA, Pfizer Inc., Radius Health Inc., Sanofi SA, Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., TSUMURA and Co., Vivesto AB, and Mithra Pharmaceuticals SA

Market Dynamics

Parent market analysis, market growth inducers and obstacles, fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for forecast period

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Browse Health Care Market Reports

Table of Contents

1 Executive Summary

  • 1.1 Market overview 
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
    • Exhibit 06: Executive Summary – Chart on Incremental Growth
    • Exhibit 07: Executive Summary – Data Table on Incremental Growth
    • Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem 
    • Exhibit 09: Parent market
    • Exhibit 10: Market Characteristics

3 Market Sizing

  • 3.1 Market definition 
    • Exhibit 11: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis 
    • Exhibit 12: Market segments
  • 3.3 Market size 2021
  • 3.4 Market outlook: Forecast for 2021-2026 
    • Exhibit 13: Chart on Global – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 14: Data Table on Global – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
    • Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

  • 4.1 Five forces summary 
    • Exhibit 17: Five forces analysis – Comparison between 2021 and 2026
  • 4.2 Bargaining power of buyers 
    • Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026
  • 4.3 Bargaining power of suppliers 
    • Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026
  • 4.4 Threat of new entrants 
    • Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026
  • 4.5 Threat of substitutes 
    • Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026
  • 4.6 Threat of rivalry 
    • Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026
  • 4.7 Market condition 
    • Exhibit 23: Chart on Market condition – Five forces 2021 and 2026

5 Market Segmentation by Type

  • 5.1 Market segments 
    • Exhibit 24: Chart on Type – Market share 2021-2026 (%)
    • Exhibit 25: Data Table on Type – Market share 2021-2026 (%)
  • 5.2 Comparison by Type 
    • Exhibit 26: Chart on Comparison by Type
    • Exhibit 27: Data Table on Comparison by Type
  • 5.3 Fertility – Market size and forecast 2021-2026
    • Exhibit 28: Chart on Fertility – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 29: Data Table on Fertility – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 30: Chart on Fertility – Year-over-year growth 2021-2026 (%)
    • Exhibit 31: Data Table on Fertility – Year-over-year growth 2021-2026 (%)
  • 5.4 Oncology – Market size and forecast 2021-2026
    • Exhibit 32: Chart on Oncology – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 33: Data Table on Oncology – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 34: Chart on Oncology – Year-over-year growth 2021-2026 (%)
    • Exhibit 35: Data Table on Oncology – Year-over-year growth 2021-2026 (%)
  • 5.5 Menopause – Market size and forecast 2021-2026
    • Exhibit 36: Chart on Menopause – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 37: Data Table on Menopause – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 38: Chart on Menopause – Year-over-year growth 2021-2026 (%)
    • Exhibit 39: Data Table on Menopause – Year-over-year growth 2021-2026 (%)
  • 5.6 Infection – Market size and forecast 2021-2026
    • Exhibit 40: Chart on Infection – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 41: Data Table on Infection – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 42: Chart on Infection – Year-over-year growth 2021-2026 (%)
    • Exhibit 43: Data Table on Infection – Year-over-year growth 2021-2026 (%)
  • 5.7 Others – Market size and forecast 2021-2026
    • Exhibit 44: Chart on Others – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 45: Data Table on Others – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 46: Chart on Others – Year-over-year growth 2021-2026 (%)
    • Exhibit 47: Data Table on Others – Year-over-year growth 2021-2026 (%)
  • 5.8 Market opportunity by Type 
    • Exhibit 48: Market opportunity by Type ($ billion)

6 Customer Landscape

  • 6.1 Customer landscape overview 
    • Exhibit 49: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

  • 7.1 Geographic segmentation 
    • Exhibit 50: Chart on Market share by geography 2021-2026 (%)
    • Exhibit 51: Data Table on Market share by geography 2021-2026 (%)
  • 7.2 Geographic comparison 
    • Exhibit 52: Chart on Geographic comparison
    • Exhibit 53: Data Table on Geographic comparison
  • 7.3 North America – Market size and forecast 2021-2026
    • Exhibit 54: Chart on North America – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 55: Data Table on North America – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 56: Chart on North America – Year-over-year growth 2021-2026 (%)
    • Exhibit 57: Data Table on North America – Year-over-year growth 2021-2026 (%)
  • 7.4 Europe – Market size and forecast 2021-2026
    • Exhibit 58: Chart on Europe – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 59: Data Table on Europe – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 60: Chart on Europe – Year-over-year growth 2021-2026 (%)
    • Exhibit 61: Data Table on Europe – Year-over-year growth 2021-2026 (%)
  • 7.5 Asia – Market size and forecast 2021-2026
    • Exhibit 62: Chart on Asia – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 63: Data Table on Asia – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 64: Chart on Asia – Year-over-year growth 2021-2026 (%)
    • Exhibit 65: Data Table on Asia – Year-over-year growth 2021-2026 (%)
  • 7.6 Rest of World (ROW) – Market size and forecast 2021-2026
    • Exhibit 66: Chart on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 67: Data Table on Rest of World (ROW) – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 68: Chart on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
    • Exhibit 69: Data Table on Rest of World (ROW) – Year-over-year growth 2021-2026 (%)
  • 7.7 US – Market size and forecast 2021-2026
    • Exhibit 70: Chart on US – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 71: Data Table on US – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 72: Chart on US – Year-over-year growth 2021-2026 (%)
    • Exhibit 73: Data Table on US – Year-over-year growth 2021-2026 (%)
  • 7.8 Germany – Market size and forecast 2021-2026
    • Exhibit 74: Chart on Germany – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 75: Data Table on Germany – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 76: Chart on Germany – Year-over-year growth 2021-2026 (%)
    • Exhibit 77: Data Table on Germany – Year-over-year growth 2021-2026 (%)
  • 7.9 UK – Market size and forecast 2021-2026
    • Exhibit 78: Chart on UK – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 79: Data Table on UK – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 80: Chart on UK – Year-over-year growth 2021-2026 (%)
    • Exhibit 81: Data Table on UK – Year-over-year growth 2021-2026 (%)
  • 7.10 China – Market size and forecast 2021-2026
    • Exhibit 82: Chart on China – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 83: Data Table on China – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 84: Chart on China – Year-over-year growth 2021-2026 (%)
    • Exhibit 85: Data Table on China – Year-over-year growth 2021-2026 (%)
  • 7.11 Canada – Market size and forecast 2021-2026 
    • Exhibit 86: Chart on Canada – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 87: Data Table on Canada – Market size and forecast 2021-2026 ($ billion)
    • Exhibit 88: Chart on Canada – Year-over-year growth 2021-2026 (%)
    • Exhibit 89: Data Table on Canada – Year-over-year growth 2021-2026 (%)
  • 7.12 Market opportunity by geography 
    • Exhibit 90: Market opportunity by geography ($ billion)

8 Drivers, Challenges, and Trends

  • 8.1 Market drivers
  • 8.2 Market challenges
  • 8.3 Impact of drivers and challenges 
    • Exhibit 91: Impact of drivers and challenges in 2021 and 2026
  • 8.4 Market trends

9 Vendor Landscape

  • 9.1 Overview
  • 9.2 Vendor landscape 
    • Exhibit 92: Overview on Criticality of inputs and Factors of differentiation
  • 9.3 Landscape disruption 
    • Exhibit 93: Overview on factors of disruption
  • 9.4 Industry risks 
    • Exhibit 94: Impact of key risks on business

10 Vendor Analysis

  • 10.1 Vendors covered 
    • Exhibit 95: Vendors covered
  • 10.2 Market positioning of vendors 
    • Exhibit 96: Matrix on vendor position and classification
  • 10.3 Abbott Laboratories 
    • Exhibit 97: Abbott Laboratories – Overview
    • Exhibit 98: Abbott Laboratories – Business segments
    • Exhibit 99: Abbott Laboratories – Key news
    • Exhibit 100: Abbott Laboratories – Key offerings
    • Exhibit 101: Abbott Laboratories – Segment focus
  • 10.4 AbbVie Inc. 
    • Exhibit 102: AbbVie Inc. – Overview
    • Exhibit 103: AbbVie Inc. – Product / Service
    • Exhibit 104: AbbVie Inc. – Key offerings
  • 10.5 Amgen Inc. 
    • Exhibit 105: Amgen Inc. – Overview
    • Exhibit 106: Amgen Inc. – Product / Service
    • Exhibit 107: Amgen Inc. – Key offerings
  • 10.6 Bayer AG 
    • Exhibit 108: Bayer AG – Overview
    • Exhibit 109: Bayer AG – Business segments
    • Exhibit 110: Bayer AG – Key offerings
    • Exhibit 111: Bayer AG – Segment focus
  • 10.7 Eli Lilly and Co. 
    • Exhibit 112: Eli Lilly and Co. – Overview
    • Exhibit 113: Eli Lilly and Co. – Product / Service
    • Exhibit 114: Eli Lilly and Co. – Key offerings
  • 10.8 F. Hoffmann La Roche Ltd. 
    • Exhibit 115: F. Hoffmann La Roche Ltd. – Overview
    • Exhibit 116: F. Hoffmann La Roche Ltd. – Business segments
    • Exhibit 117: F. Hoffmann La Roche Ltd. – Key news
    • Exhibit 118: F. Hoffmann La Roche Ltd. – Key offerings
    • Exhibit 119: F. Hoffmann La Roche Ltd. – Segment focus
  • 10.9 ICON plc 
    • Exhibit 120: ICON plc – Overview
    • Exhibit 121: ICON plc – Product / Service
    • Exhibit 122: ICON plc – Key offerings
  • 10.10 Merck KGaA 
    • Exhibit 123: Merck KGaA – Overview
    • Exhibit 124: Merck KGaA – Business segments
    • Exhibit 125: Merck KGaA – Key news
    • Exhibit 126: Merck KGaA – Key offerings
    • Exhibit 127: Merck KGaA – Segment focus
  • 10.11 Mithra Pharmaceuticals SA 
    • Exhibit 128: Mithra Pharmaceuticals SA – Overview
    • Exhibit 129: Mithra Pharmaceuticals SA – Product / Service
    • Exhibit 130: Mithra Pharmaceuticals SA – Key offerings
  • 10.12 Novartis AG 
    • Exhibit 131: Novartis AG – Overview
    • Exhibit 132: Novartis AG – Business segments
    • Exhibit 133: Novartis AG – Key offerings
    • Exhibit 134: Novartis AG – Segment focus

11 Appendix

  • 11.1 Scope of the report
  • 11.2 Inclusions and exclusions checklist 
    • Exhibit 135: Inclusions checklist
    • Exhibit 136: Exclusions checklist
  • 11.3 Currency conversion rates for US$ 
    • Exhibit 137: Currency conversion rates for US$
  • 11.4 Research methodology 
    • Exhibit 138: Research methodology
    • Exhibit 139: Validation techniques employed for market sizing
    • Exhibit 140: Information sources
  • 11.5 List of abbreviations 
    • Exhibit 141: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provide actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/womens-health-therapeutics-market-size-to-grow-by-usd-30-35-billion-rising-awareness-about-gynecological-diseases-to-be-a-key-trend—technavio-301632927.html

SOURCE Technavio

Women's Health Therapeutics Market Size to Grow by USD 30.35 billion, Rising Awareness about Gynecological Diseases to be a Key Trend - Technavio WeeklyReviewer

PR Newswire Science News

World Reviewer Staff
World Reviewer Staffhttps://weeklyreviewer.com/
The first logical thought has to be "no way". I'm the World Observer! Ill find and share important news all day.

Latest articles

Earnings Disclosure

WeeklyReviewer earns primarily through affiliates and ads. We don’t encourage anyone to click on ads for any other purpose but your own. We recommend products and services often for our readers, and through many we will earn commissions through affiliate programs.

Related articles